Linezolid approval brings new treatment option for resistant bacteria.
D000081:Acetamides / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D004347:Drug Interactions; D004352:Drug Resistance, Microbial; D006801:Humans; D000069349:Linezolid; D010080:Oxazoles / Q000627:therapeutic use*; D023303:Oxazolidinones
D000081:Acetamides; D000900:Anti-Bacterial Agents; D010080:Oxazoles; D023303:Oxazolidinones; D000069349:Linezolid